Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 9901 Records) |
| Query Trace: Breast cancer[original query] |
|---|
| Analysis of Interleukin-6 Gene Variants (rs1800795, rs1800796, rs1554606, rs1800797, rs2069840, rs12700386, and rs2069861) as Prognostic Markers in Breast Cancer: A Systematic Review, Meta-Analysis, and Network Analysis. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2023 11 . Ali Azizi, Nasrin Mansouri, Mitra Tarlan, Masoud Sadeg |
| Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China. Frontiers in genetics 2023 11 14 1271710. Yinfeng Liu, Jie Zheng, Yue Xu, Ji Lv, Zizheng Wu, Kai Feng, Jiani Liu, Weitao Yan, Liguang Wei, Jiangman Zhao, Lisha Jiang, Meng H |
| Mutational Landscape and In-Silico Analysis of TP53, PIK3CA, and PTEN in Patients with Breast Cancer from Khyber Pakhtunkhwa. ACS omega 2023 11 8 (45): 43318-43331. Hilal Ahmad, Asif Ali, Roshan Ali, Ali Talha Khalil, Ishaq Khan, Mah Muneer Khan, Mohammed Alori |
| Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features. Cureus 2023 11 15 (10): e47324. Oktay Ünsal, Bü?ra Güvercin, Ahmet Özet, Mehmet Ali Erg |
| INO80 function is required for mouse mammary gland development, but mutation alone may be insufficient for breast cancer. Frontiers in cell and developmental biology 2023 11 11 1253274. Nguyen Xuan Thang, Dong Wook Han, Chanhyeok Park, Hyeonji Lee, Hyeonwoo La, Seonho Yoo, Heeji Lee, Sang Jun Uhm, Hyuk Song, Jeong Tae Do, Kyoung Sik Park, Youngsok Choi, Kwonho Ho |
| Cis - and trans -eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia. bioRxiv : the preprint server for biology 2023 11 . S Taylor Head, Felipe Dezem, Andrei Todor, Jingjing Yang, Jasmine Plummer, Simon Gayther, Siddhartha Kar, Joellen Schildkraut, Michael P Epste |
| Mutational and expressional association of the PIK3CA gene with the risk of breast cancer in the Pakistani population. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 1-8. Samina Asghar Abbasi, Rashida Khan, Mehvish Naseer Ahmed, Kashif Hussain, Aayesha Riaz, Qaisar Mansoor, Mazhar Qayyum, Ruqia Mehmood Ba |
| Detection of TP53 gene mutation in blood of breast cancer patients based on circulating tumor DNA and its application in prognosis. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 200-206. Qiran Lu, Luxin Wei, Shenbin Cai, Zhe Zhang, Lifeng Zha |
| Exome Sequencing Reveals Novel Germline Variants in Breast Cancer Patients in the Southernmost Region of Thailand. Journal of personalized medicine 2023 11 13 (11): . Panupong Sukpan, Surasak Sangkhathat, Hutcha Sriplung, Wison Laochareonsuk, Pongsakorn Choochuen, Nasuha Auseng, Weerawan Khoonjan, Rusta Salaeh, Kornchanok Thangnaphadol, Kasemsun Wanawanakorn, Kanyanatt Kanokwiro |
| Association of Germline Variation in Driver Genes with Breast Cancer Risk in Chilean Population. International journal of molecular sciences 2023 11 24 (22): . Sebastián Morales-Pison, Julio C Tapia, Sarai Morales-González, Edio Maldonado, Mónica Acuña, Gloria M Calaf, Lilian Ja |
| Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors. Genes 2023 11 14 (11): . Monica A Wagner, Theresa A Koleck, Alex Conway, Catherine M Bender, Yvette P Conl |
| The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer. Cancers 2023 11 15 (22): . Woong Ki Park, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Jai Min Ryu, Byung Joo Ch |
| Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. Human pathology 2023 11 . Baris Boyraz, Amy |
| Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients. The oncologist 2023 11 . Jiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, Laura Min Xuan Chai, Mei-Hsuan Lee, Chun-Yu Liu, Yi-Fang Tsai, Chi-Cheng Huang, Ling-Ming Tseng, Cheng-Chih Hsu, Ta-Chung Ch |
| Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature. JCO precision oncology 2023 11 7 e2300091. Felipe Batalini, Russell W Madison, Ethan S Sokol, Dexter X Jin, Kuei-Ting Chen, Brennan Decker, Dean C Pavlick, Garrett M Frampton, Gerburg M Wulf, Judy E Garber, Geoffrey Oxnard, Alexa B Schrock, Nadine M Tu |
| Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
| ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1 mutant breast cancer. Cancer discovery 2023 11 . Belinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, Li-Xuan Sim, Rosalind J Cutts, Heena Shah, Laura Moretti, Lucy S Kilburn, Hannah Johnson, Iain R Macpherson, Alistair Ring, Judith M Bliss, Yingwei Hou, Weiyi Toy, John A Katzenellenbogen, Sarat Chandarlapaty, Nicholas C Turn |
| Genomic analysis of breast cancer patients from Kerala: A novel BRCA1 mutation detected. Breast disease 2023 11 42 (1): 341-347. Adarsh Dharmarajan, Vipin Gopinath, Sangeetha Keloth Nayanar, Sobhith Velandi Kunnummal, Satheesan Balasubramanian, Deepak Roshan Valiyaparambil Go |
| Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature communications 2023 11 14 (1): 7496. P Tarantino, H Gupta, M E Hughes, J Files, S Strauss, G Kirkner, A-M Feeney, Y Li, A C Garrido-Castro, R Barroso-Sousa, B L Bychkovsky, S DiLascio, L Sholl, L MacConaill, N Lindeman, B E Johnson, M Meyerson, R Jeselsohn, X Qiu, R Li, H Long, E P Winer, D Dillon, G Curigliano, A D Cherniack, S M Tolaney, N U L |
| Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of pharmaceutical and biomedical analysis 2023 11 238 115839. Fatemeh Saghafi, Ebrahim Salehifar, Pouneh Ebrahimi, Mohammad Reza Shiran, Ehsan Zaboli, Seyed Mojtaba Sohrevardi, Tannaz Jamialahmadi, Adeleh Sahebnasagh, Amirhossein Sahebk |
| Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. Signal transduction and targeted therapy 2023 11 8 (1): 429. Yiqun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe |
| Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib. JCO precision oncology 2023 11 7 e2300295. Malini M Gandhi, Biagio Ricciuti, Guilherme Harada, Matteo Repetto, Melissa S Gildenberg, Ankit Singh, Yvonne Y Li, Andréanne Gagné, Xinan Wang, Ayal Aizer, Kelly Fitzgerald, Mizuki Nishino, Joao Alessi, Federica Pecci, Alessandro Di Federico, Adam Fisch, Alexander Drilon, Valentina Nardi, Lynette Sholl, Mark M Awad, Julia Rot |
| The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? Annals of translational medicine 2023 11 11 (11): 393. Stanislas Quesada, William Jac |
| GSK3? rs3107669 polymorphism implicates chemotherapy-associated retrospective memory deficits in breast cancer survivors. American journal of cancer research 2023 11 13 (10): 4961-4975. Wen Li, Chen Gan, Sheng Yu, Jian Xu, Lingxue Tang, Qiang Li, Zhenwei Zhu, Huaidong Che |
| Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. American journal of translational research 2023 11 15 (10): 6026-6041. Jiaoping Mi, Juncong Luo, Huanwen Zeng, Hongyu Zhang, Muhammad Jamil, Mostafa A Abdel-Maksoud, Adel M Zakri, Akram A Alfuraydi, Ning Zhang, Mei Xi |
| Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer. Acta oncologica (Stockholm, Sweden) 2023 11 1-8. Frances M Reznitsky, Jeanette D Jensen, Ann Knoop, Maj-Britt Jensen, Anne-Vibeke Laenkho |
| The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times. International journal of molecular sciences 2023 11 24 (21): . Paolo Aretini, Silvano Presciuttini, Aldo Pastore, Alvaro Galli, Sara Panepinto, Mariella Tancredi, Matteo Ghilli, Chiara Guglielmi, Diletta Sidoti, Caterina Congregati, Maria Adelaide Cali |
| Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience. Hereditary cancer in clinical practice 2023 11 21 (1): 23. Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagaya |
| The association between thyroid and breast cancers: a bidirectional mendelian randomization study. Frontiers in endocrinology 2023 11 14 1185497. Jinchi Liu, Leifeng Lia |
| Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease. Gene 2023 11 147980. Ashish Singh, Josh Thomas Georgy, Sakthi Dhananjayan, Elanthenral Sigamani, Ajoy Oommen John, Anjana Joel, Jagan Chandramohan, Rajadurai Abarna, Grace Rebekah, Selvamani Backianathan, Deepak Thomas Abraham, Mazhuvanchary Jacob Paul, Raju Titus Chacko, Marie Therese Manipadam, Rekha P |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: